A Sudan Ebola vaccine, provided by the International AIDS Vaccine Initiative (IAVI), is being investigated in a Uganda ...

The World Health Organization director for Africa said Uganda has started a clinical trial of a vaccine against the Sudan strain of Ebola, for which there is currently no approved vaccine.

In 2022, during a previous outbreak of Ebola from the Sudan strain in Uganda, a randomized protocol for candidate vaccines ...

KAMPALA, Uganda — Ugandan authorities on Monday began a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week.

A trial of one or possibly two experimental vaccines to protect against the Ebola Sudan virus may begin shortly in Uganda, where there have been at least 36 cases and 23 deaths from the virus.

First Participants Vaccinated with IAVI’s Ebola Sudan Vaccine Candidate in Uganda Amid Ebola Outbreak ACCESSWIRE. Updated February 3, 2025 11:25 AM.

World Health Organization chief Tedros Adhanom Ghebreyesus said on Wednesday a clinical trial of vaccines to combat the Sudan strain of Ebola could start within weeks as an outbreak of the disease ...

More about IAVI's investigational Ebola Sudan vaccine candidate. In 2023, IAVI initiated a Phase 1 clinical trial of its rVSV-based Ebola Sudan vaccine candidate.

An effort to test several Ebola Sudan vaccines in Uganda in 2022 was abandoned because the outbreak was contained before the trial could be done. This time, years of planning to persuade countries ...

To A, Wong TA, Ball A, et al. Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine . Published online January 25, 2024 ...

The vaccine maker wasn’t immediately known. There are no approved vaccines for the Sudan strain of Ebola that killed a nurse employed at Kampala’s main referral hospital.

More about IAVI's investigational Ebola Sudan vaccine candidate. In 2023, IAVI initiated a Phase 1 clinical trial of its rVSV-based Ebola Sudan vaccine candidate.